Pure Global

SMYLS Multi-site Trial - Trial NCT06035939

Access comprehensive clinical trial information for NCT06035939 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of South Carolina and is currently Not yet recruiting. The study focuses on Sickle Cell Disease. Target enrollment is 272 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06035939
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06035939
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
SMYLS Multi-site Trial
Self-Management for Youth Living With Sickle Cell Disease: SMYLS Multi-site Trial

Study Focus

Sickle Cell Disease

Voice Crisis Alert V2

Interventional

behavioral

Sponsor & Location

Medical University of South Carolina

Charleston, United States of America

Timeline & Enrollment

N/A

Dec 01, 2023

Jan 01, 2028

272 participants

Primary Outcome

Self-management behaviors

Summary

The purpose of this study is to find out whether a web-based intervention using a mobile app
 is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care
 for and manage their symptoms.

ICD-10 Classifications

Sickle-cell disorders
Other sickle-cell disorders
Sickle-cell trait
Sickle-cell anaemia with crisis
Sickle-cell anaemia without crisis

Data Source

ClinicalTrials.gov

NCT06035939

Non-Device Trial